8 set 2020 ano - • AstraZeneca halts their Phase III vaccine trial due to safety reasons. • The Pfizer-BioNTech partnership expand their Phase III trial by 50% to increase data on safety and efficacy in a more diverse population. Vaccine is administered in 2 shots, 3 weeks apart. Storage conditions are a challenge.
Adicionado na linha do tempo:
Data:
8 set 2020 ano
Agora
~ 3 years and 8 months ago
